Company Filing History:
Years Active: 2025
Title: Jan Spanholtz: Innovator in Cancer Treatment
Introduction
Jan Spanholtz is a prominent inventor based in AB Oss, Netherlands. He has made significant contributions to the field of medicine, particularly in the development of innovative cancer treatments. His work focuses on the manufacturing of Natural Killer (NK) cells, which are crucial in the fight against cancer.
Latest Patents
Jan Spanholtz holds a patent for a method of manufacturing CAR NK cells. This method involves genetically modifying NK cells with lentiviral vectors that carry a polynucleotide coding for Chimeric Antigen Receptors (CARs). The CAR-NK cells produced using this method have shown promise in medical applications, especially in treating cancer.
Career Highlights
Spanholtz is associated with Glycostem Therapeutics B.V., a company dedicated to advancing cell therapy technologies. His innovative approach to NK cell manufacturing has positioned him as a key player in the field of immunotherapy.
Collaborations
Jan Spanholtz collaborates with talented professionals in his field, including Nina Kok and Alessandra Gatti. Their combined expertise enhances the research and development efforts at Glycostem Therapeutics B.V.
Conclusion
Jan Spanholtz's contributions to the field of cancer treatment through his innovative patent and collaboration with skilled colleagues highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options in oncology.